The compounds of formula (I) and their pharmaceutically acceptable salts are disclosed as being useful in the treatment of schizophrenia-associated cognitive deficits and other psychiatric, neurodegenerative and / or neurological disorders in mammals, including humans. (I) Wherein X, Y, Z, R 1 , R 2 , R 3 , R 4 are as defined herein.
展开▼
